Concierge Longevity Physician in Pennsylvania

Pennsylvania's Health Fiduciary. Physician-led longevity medicine for those who manage everything — except their biological capital.
Board-certified in Gastroenterology
by American Board of Internal Medicine

Board-certified gastroenterologist-led longevity medicine for Philadelphia, the Main Line, Pittsburgh, and high-performing Pennsylvania families. Virtual care, clinical precision, total discretion.

Who We Serve

Physician-led longevity medicine for Pennsylvania's most demanding principals, executives, and multi-generational families. Whether you’re based in Philadelphia, Pittsburgh, or anywhere across the state, your care is fully managed and seamlessly integrated into your schedule.

I. The Institutional Founder & Main Line Principal

You manage a complex enterprise — a family office, a multi-generational legacy, or a global operation — from a primary residence in Villanova, Haverford, Gladwyne, or Bryn Mawr. Your financial capital is rigorously stewarded. Your health is the primary engine of that legacy and deserves the same depth of oversight. LongevIQ GI provides a clinical partnership built on advanced diagnostics, longitudinal accountability, and a physician who functions as a Health Fiduciary — unconflicted, proactive, and entirely on your terms.

II. The Center City Power Architect

You are a Philadelphia executive, private equity partner, or senior operator who values time above all else. You require a virtual-first, data-intensive clinical model that integrates without friction into a high-stakes schedule. From the historic residences of Society Hill to the premier corridors of Rittenhouse Square and Fitler Square, LongevIQ GI delivers precision longevity stewardship directly to your environment — no clinic visits, no waiting rooms, no compromised discretion.

III. The Western Pennsylvania Visionary

For the principals of Pittsburgh’s industrial, technology, and healthcare sectors who expect a peer-to-peer clinical relationship with a board-certified specialist. Whether you reside in the ultra-private boundaries of Sewickley Heights and Edgeworth, or in the established corridors of Fox Chapel and Shadyside, LongevIQ GI delivers the same clinical precision available to any client — entirely virtually, on your schedule, with complete discretion.

IV. The Legacy Estate & Tech Corridor Leader

For the discerning family principal who views healthspan extension as a long-term capital investment. Designed for residents of the Bucks County estate tier — New Hope, Solebury, Washington Crossing — as well as the pharmaceutical and technology leaders of Malvern, Devon, and Berwyn. You demand PubMed-indexed clinical rigor and a physician who operates entirely outside the insurance system. That is what a Health Fiduciary delivers.

V. The Multi-Residence Client

Your life moves between a primary residence in Pennsylvania, a second home in Florida, and a professional schedule that makes traditional clinic relationships impractical. LongevIQ GI is fully virtual and licensed across Pennsylvania, Florida, and Texas. Whether you are in Philadelphia, Palm Beach, or Houston, your protocol travels with you — and your physician remains consistent.

Precision Medicine Philadelphia — The Gut Is Where Biological Age Is Set

Standard longevity protocols ignore the gut — the primary regulator of systemic inflammation and biological age. Circulating microbial metabolites, intestinal barrier integrity, and microbiome-derived SCFA production are upstream variables that determine how every downstream intervention performs. CoQ10 and NAD+ supplementation demonstrate measurably reduced efficacy when gut dysbiosis persists. Epigenetic clocks accelerate when barrier function is compromised. This is the gap that no generalist longevity platform addresses.

At LongevIQ GI, every protocol begins with the biology that the rest of the field omits. Led by a board-certified gastroenterologist with deep microbiome expertise and over 15 years of clinical and research experience, we build longevity strategies from the gut up — because that is where biological age is actually set. Dr. Banerjee operates entirely outside the insurance system — no volume incentives, no conflicted referral networks. Clinical loyalty to one principal: you.

Why Early Detection Changes Everything

Breakthrough diagnostics uncover risks years before symptoms appear — giving you the advantage of time.

85%
Ref: Chang, D., Gupta, V.K., Hur, B. et al. Gut Microbiome Wellness Index 2 enhances health status prediction from gut microbiome taxonomic profiles. Nat Commun 15, 7447 (2024)

is the accuracy with which gut microbiome can distinguish healthy to diseased individual[1]

68%
Ref: POLARIS Study: Early Findings Presented at the American Association for Cancer Research (AACR) Annual Meeting,2025. Prenuvo,Inc.

of cancers detected on preventive whole-body MRI have no recommended screening pathway[2]

Ref: Nabavizadeh N et al. PATHFINDER-2 Interim Analysis. Ann Oncol 2025

increase in cancer detection when MCED (multi cancer early-detection) blood test is combined with recommended standard screening[3]

Subhra “Sam” Banerjee

MD, FACG, FACP 

Gastroenterologist | Longevity Physician | Founder, LongevIQ GI

15 years of clinical and research experience, now applied exclusively to precision longevity and gut-informed biological optimization.

Board-Certified Gastroenterologist

Fellowship: Gastroenterology & Hepatology, Mount Sinai Health System, New York City

Fellow, American College of Gastroenterology (FACG)  |  Fellow, American College of Physicians (FACP)

Clinical Researcher  |  Phase III Trials  |  PubMed-Indexed Publications  |  AI Diagnostics in Gastroenterology

The Process

We’ve designed a streamlined, white-glove experience that delivers high-impact insights and measurable outcomes — entirely virtually

0
1
2
3
01

Deep Phenotyping

Advanced gut microbiome sequencing, epigenetic age analysis, comprehensive cardiometabolic profiling, toxic load assessment, and VO₂ max evaluation. We establish your complete biological baseline — not a snapshot, a full systems map.

02

Strategic Protocol

A personalized longevity roadmap built from your diagnostic data. Every intervention is evidence-anchored. Supplements and nutraceuticals are deployed only where clinical evidence is unambiguous. The protocol is yours — designed around how your life is actually structured.

03

Active Stewardship

Quarterly physician-led optimization and refinement. Your biology changes; your protocol adapts. Ongoing direct access to Dr. Banerjee — not a care coordinator, not a patient portal. The physician.

I am fortunate to have had Dr. Banerjee as my personal physician for several years. From the start, he has been genuinely engaged with his patients, listening carefully and explaining tests and recommendations in a calm, intelligent, and reassuring way. I have recommended him to family and friends as an outstanding physician who truly cares. It has often occurred to me that he would make a wonderful medical professor, teaching young doctors to care for both the mind and body with intelligence and compassion.
Maria G.
“Dr. Banerjee is a very attentive and thoughtful practitioner. While under his care, he placed special emphasis on explaining treatments, fully answered all my questions, and ensured that my concerns received his complete attention. As a patient, this made me feel respected and confident that I received a world-class level of care.”
John C.

Pennsylvania residents: your longevity protocol begins with a single conversation.

LongevIQ GI is a physician-led, fully virtual practice serving clients across Philadelphia, Pittsburgh, and Pennsylvania statewide — and licensed in Florida and Texas. Evening and weekend availability. Complete discretion.

No referral required. No commitment. 30 minutes with Dr. Banerjee.

Citations:
  1. Chang, D., Gupta, V.K., Hur, B. et al. Gut Microbiome Wellness Index 2 enhances health status prediction from gut microbiome taxonomic profiles. Nat Commun 15, 7447 (2024)
  2. POLARIS Study: Early Findings Presented at the American Association for Cancer Research (AACR) Annual Meeting,2025. Prenuvo,Inc.
  3. Nabavizadeh N et al. PATHFINDER-2 Interim Analysis. Ann Oncol 2025